BeOne Medicines Ltd (6160) Gets a Buy from Nomura
Chinese biotech overtakes AI as emerging-market growth trade
10:30 ETSingle-use Bioreactors Market worth $9.58 billion by 2031 - Exclusive Report by MarketsandMarkets™
China's 1H25 Innovative Drug Out-Licensing Deal Value Exceeds USD100 Billion, Hitting New High
China's Humanoid Robot Products Exceed 400 Models, Accounting for Over Half of Global Total
BeOne Medicines CEO John Oyler reports disposal of shares worth $75.72 million